rectal cancer

Research in Review

Noncompliance With NCCN Guidelines Can Worsen Rectal Cancer Survival

08/31/2016

JCP Editors

Not complying with recommendations found in National Comprehensive Cancer Network (NCCN) guidelines for locally advanced rectal cancer may led to worse overall survival, according to a study published in the journal...

Not...

08/31/2016

Journal of Clinical Pathways

Research in Review

Rectal Cancer Treatment Utilizing Chemotherapy and Radiation Therapy Improving Over Time

06/20/2016

JCP Editors

A review of the last decade of care for rectal cancer has found evidence of significant progress in improving patient outcomes despite a number of challenges. For their review, researchers led by Nader N...

...

06/20/2016

Journal of Clinical Pathways

Research in Review

Standard Therapy Only Used in Half of US Patients With Rectal Cancer

04/20/2016

JCP Editors

Despite being widely accepted as the standard of care for locally advanced rectal cancer, neoadjuvant chemoradiation (NACRT) is only used in about half of US patients with the disease, according to a recent...

...

04/20/2016

Journal of Clinical Pathways

Research in Review

Non-Operative Management for Rectal Cancer on the Rise Despite Lack of Evidence

04/04/2016

JCP Editors

The use of neoadjuvant chemoradiation for stage 2 and 3 rectal cancer is on the rise, but researchers are unsure whether this represents treatment innovation or greater disparity in cancer care. Currently, the...

The...

04/04/2016

Journal of Clinical Pathways

Shorter Radiation Courses Safer and Equally Effective for Rectal Cancer Patients

01/19/2016

JCP Editors

Shorter radiation courses followed by consolidation chemotherapy before surgery may be an effective treatment option for rectal cancer patients. High volume bouts of chemoradiation are often used before surgery in...

...

01/19/2016

Journal of Clinical Pathways